Although specific investigations into the link between YAP/TAZ and inflammation in MASLD are warranted, insights from general liver injury models suggest that YAP dysregulation in hepatocytes promotes the production of pro-inflammatory cytokines that exacerbate the disease (Mooring et al. 2020). Here, YAP1 is linked to metabolic dysfunction-associated steatotic liver disease.